These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6432722)

  • 1. The cytokinetic and cytotoxic effects of ICRF-159 and ICRF-187 in vitro and ICRF-187 in human bone marrow in vivo.
    Wheeler RH; Clauw DJ; Natale RB; Ruddon RW
    Invest New Drugs; 1983; 1(4):283-95. PubMed ID: 6432722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokinetic evaluation of the four-drug combination of bleomycin, vincristine, mitomycin C, and methotrexate (BOMM) in cultured Burkitt's lymphoma cells and human bone marrow.
    Wheeler RH; Clauw DJ; O'Toole TE; Ensminger WD
    Cancer; 1982 Nov; 50(10):1993-9. PubMed ID: 6181861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICRF 159-induced cell-cycle perturbation in vitro: its relationship to inhibition of colony-forming ability.
    Edgar DH; Creighton AM
    Br J Cancer; 1981 Aug; 44(2):236-40. PubMed ID: 7023524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors.
    Ishida R; Miki T; Narita T; Yui R; Sato M; Utsumi KR; Tanabe K; Andoh T
    Cancer Res; 1991 Sep; 51(18):4909-16. PubMed ID: 1654205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines.
    Lu DY; Huang M; Xu CH; Yang WY; Hu CX; Lin LP; Tong LJ; Li MH; Lu W; Zhang XW; Ding J
    BMC Pharmacol; 2005 Jun; 5():11. PubMed ID: 15963241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal and sublethal effects of the combination of doxorubicin and the bisdioxopiperazine, (+)-1,2,-bis (3-5-dioxopiperazinyl-1-yl) propane (ICRF 187), on murine sarcoma S180 in vitro.
    Wadler S; Green MD; Basch R; Muggia FM
    Biochem Pharmacol; 1987 May; 36(9):1495-501. PubMed ID: 3107574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of radiation and AT 1727 in HeLa S-3 cells in culture.
    He SQ; Kim SH; Kim JH
    Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1137-42. PubMed ID: 3997596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane; ADR-529] and ICRF-159 (Razoxane).
    Gorbsky GJ
    Cancer Res; 1994 Feb; 54(4):1042-8. PubMed ID: 8313360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in sensitivity to radiation and ICRF 159 during the life of monolayer cultures of EMT6 tumour line.
    Taylor IW; Bleehen NM
    Br J Cancer; 1977 May; 35(5):587-94. PubMed ID: 861147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the biological and biochemical activities of F 11782 and the bisdioxopiperazines, ICRF-187 and ICRF-193, two types of topoisomerase II catalytic inhibitors with distinctive mechanisms of action.
    van Hille B; Etiévant C; Barret JM; Kruczynski A; Hill BT
    Anticancer Drugs; 2000 Nov; 11(10):829-41. PubMed ID: 11142691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisdioxopiperazine, (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187), enhances the antiproliferative effect of cisplatin on human ovarian cancer cells.
    Scambia G; Della Bitta R; Benedetti Panici P; De Vincenzo R; Contu G; Ercoli A; Bonanno G; Pierelli L; Mancuso S
    Gynecol Oncol; 1995 Apr; 57(1):16-22. PubMed ID: 7705696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of stereoisomers related to ICRF-159 on metastasis of B16 melanoma.
    Zwilling BS; Campolito LB; Reiches NA; George T; Witiak DT
    Br J Cancer; 1981 Oct; 44(4):578-83. PubMed ID: 7295515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE; Cadena RS; Raimondi SC; Beck WT
    Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines.
    Jensen LH; Nitiss KC; Rose A; Dong J; Zhou J; Hu T; Osheroff N; Jensen PB; Sehested M; Nitiss JL
    J Biol Chem; 2000 Jan; 275(3):2137-46. PubMed ID: 10636919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different susceptibilities of postmitotic checkpoint-proficient and -deficient Balb / 3T3 cells to ICRF-193, a catalytic inhibitor of DNA topoisomerase II.
    Nishida K; Seto M; Ishida R
    Jpn J Cancer Res; 2001 Feb; 92(2):193-202. PubMed ID: 11223549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric analysis of ICRF-193 influence on cell passage through mitosis].
    Shatrova A; Aksenov ND; Zenin VV
    Tsitologiia; 2002; 44(11):1068-78. PubMed ID: 12561727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of ICRF-154 in combination with other anticancer agents in vitro.
    Kano Y; Narita T; Suzuki K; Akutsu M; Suda K; Sakamoto S; Miura Y
    Br J Cancer; 1992 Aug; 66(2):281-6. PubMed ID: 1503899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of doxorubicin cytotoxicity by (+)-1,2-bis-(3,5-dioxopiperazinyl-1-yl) propane (ICRF-187) in human leukemic HL-60 cells.
    Monti E; Sinha BK
    Cancer Commun; 1990; 2(4):145-9. PubMed ID: 2164412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells.
    Sutherland RL; Hall RE; Taylor IW
    Cancer Res; 1983 Sep; 43(9):3998-4006. PubMed ID: 6871841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.